Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
First generation antihistamine (H1) of the ethanolamine type, with an anticholinergic activity and sedative effects, used in the treatment of allergic disorders.
It is a common component of medications for the symptomatic relief of the common cold (FDA 2013).
Its use is unauthorized in children under 2 years old.
Administered orally every 12 hours.
Since the last update we have not found published data on its excretion in breastmilk and the lack of available pharmacokinetic data makes it impossible to predict it.
There is very little literature in relation to this medication.
In the immediate postpartum, an inhibitory effect on the secretion of prolactin has been observed, which, however, does not influence the stimulation produced by the baby’s sucking (Messinis 1985).
There is a possibility of drowsiness with the use of high doses (Ito 1993, Chow 2015).
If used while breastfeeding, it is advisable to monitor drowsiness and the adequate feeding of the infant.
It is not recommended to share a bed with the baby if this medication is being taken (UNICEF 2013, Landa 2012, ABM 2008, UNICEF 2006).
Until there is more published data on this drug in relation to breastfeeding, safer known alternatives may be preferable, especially during the neonatal period and in case of prematurity.